Companies

Oncology Institute, Inc.

TOI, DFPH, TOIIW · CIK 0001799191 · operating

$2.98+2.94%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$290.22M
P/E
Fwd P/E-18.44
PEG
P/S0.63
P/B
EV/EBITDA-10.74
EV/Rev0.79

Profitability

Gross Margin
Op. Margin-15.28%
Net Margin-16.44%
ROE-1801.70%
ROA-37.44%
FCF Margin0.05%

Financial Health

Current Ratio2.15
Debt/Equity47.12
Free Cash Flow$211,000
Div. Yield

Growth & Other

Revenue Growth21.33%
EPS Growth22.83%
Beta0.17
52W High$4.88
52W Low$0.602

About Oncology Institute, Inc.

Oncology Institute, Inc. (TOI) is a services-offices & clinics of doctors of medicine company incorporated in DE, listed on the Nasdaq. With a market capitalization of $284 million, Oncology Institute, Inc. is a micro-cap company. The stock currently trades at $2.98, up 2.94% today, with a 52-week range of $0.60–$4.88.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-0.71$-0.71+22.8%
2023$-0.92$-0.92-338.1%
2022$-0.21$0.00-31.2%
2021$-0.16$-0.16
2020

Annual Reports (10-K) · 5 filings

Report DateFiledAccession Number
2024-12-312025-03-260001799191-25-000014SEC ↗
2023-12-312024-03-280001628280-24-013444SEC ↗
2022-12-312023-03-160001628280-23-008315SEC ↗
2021-12-312022-03-110001628280-22-005868SEC ↗
2020-12-312021-03-300001104659-21-044010SEC ↗